Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs

BACKGROUND: Mesenchymal stromal cells (MSCs) therapy for acute respiratory distress syndrome (ARDS) is an emerging treatment, but most of the current trials of MSCs stay in the animal experimental stage, and the safety and efficacy of MSCs in clinical application are not clear. We aimed to analyze t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianbao, Luo, Fenbin, Suo, Ye, Zheng, Yuxin, Chen, Kaikai, You, Deyuan, Liu, Yuqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233855/
https://www.ncbi.nlm.nih.gov/pubmed/35752865
http://dx.doi.org/10.1186/s13287-022-02956-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233855/
https://www.ncbi.nlm.nih.gov/pubmed/35752865
http://dx.doi.org/10.1186/s13287-022-02956-3

Ejemplares similares